These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32126280)

  • 1. A Europe-wide assessment of antibiotic resistance rates in Bacteroides and Parabacteroides isolates from intestinal microbiota of healthy subjects.
    Sóki J; Wybo I; Hajdú E; Toprak NU; Jeverica S; Stingu CS; Tierney D; Perry JD; Matuz M; Urbán E; Nagy E;
    Anaerobe; 2020 Apr; 62():102182. PubMed ID: 32126280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary.
    Sárvári KP; Sóki J; Kristóf K; Juhász E; Miszti C; Latkóczy K; Melegh SZ; Urbán E
    Infect Dis (Lond); 2018 May; 50(5):372-380. PubMed ID: 29303023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of resistance genes and susceptibility patterns in Bacteroides and Parabacteroides strains.
    Boente RF; Ferreira LQ; Falcão LS; Miranda KR; Guimarães PL; Santos-Filho J; Vieira JM; Barroso DE; Emond JP; Ferreira EO; Paula GR; Domingues RM
    Anaerobe; 2010 Jun; 16(3):190-4. PubMed ID: 20159050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the antibiotic resistance genes content of intestinal Bacteroides, Parabacteroides and Phocaeicola isolates from healthy and carbapenem-treated patients from European countries.
    Sóki J; Wybo I; Baaity Z; Stefán G; Jeverica S; Ulger N; Stingu CS; Mahmood B; Burián K; Nagy E
    BMC Microbiol; 2024 Jun; 24(1):202. PubMed ID: 38851699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group.
    Phillips I; King A; Nord CE; Hoffstedt B
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):292-304. PubMed ID: 1396748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study.
    Karlowsky JA; Walkty AJ; Adam HJ; Baxter MR; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1247-52. PubMed ID: 22203594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.
    Jasemi S; Emaneini M; Ahmadinejad Z; Fazeli MS; Sechi LA; Sadeghpour Heravi F; Feizabadi MM
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):27. PubMed ID: 33892721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience.
    Nagy E; Urbán E; Nord CE;
    Clin Microbiol Infect; 2011 Mar; 17(3):371-9. PubMed ID: 20456453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.
    Snydman DR; Jacobus NV; McDermott LA; Goldstein EJ; Harrell L; Jenkins SG; Newton D; Patel R; Hecht DW
    Anaerobe; 2017 Feb; 43():21-26. PubMed ID: 27867083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
    Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
    J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do antimicrobial susceptibility patterns of colonic isolates of Bacteroides species change after antibiotic prophylaxis with cefoxitine during elective abdominal surgery?
    Toprak NU; Güllüoğlu BM; Cakici O; Akin ML; Demirkalem P; Celenk T; Söyletir G
    World J Surg; 2005 Oct; 29(10):1311-5. PubMed ID: 16142428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
    Eitel Z; Sóki J; Urbán E; Nagy E;
    Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong by the tentative EUCAST disc diffusion method.
    Ho PL; Yau CY; Ho LY; Lai EL; Liu MC; Tse CW; Chow KH
    Anaerobe; 2017 Oct; 47():51-56. PubMed ID: 28414107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of Bacteroides isolates recovered among clinical samples from a major Costa Rican hospital between 2000 and 2008 to ß-lactams, clindamycin, metronidazole, and chloramphenicol.
    Cordero-Laurent E; Rodríguez C; Rodríguez-Cavallini E; Gamboa-Coronado MM; Quesada-Gómez C
    Rev Esp Quimioter; 2012 Dec; 25(4):261-5. PubMed ID: 23303257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the antimicrobial resistance of fecal Bacteroides isolates and assessment of the composition of the intestinal microbiotas of carbapenem-treated and non-treated persons from Belgium and Hungary.
    Sóki J; Wybo I; Wirth R; Hajdú E; Matuz M; Burián K;
    Anaerobe; 2022 Feb; 73():102480. PubMed ID: 34800619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and genotypic characterization of multidrug-resistant Bacteroides, Parabacteroides spp., and Pseudoflavonifractor from a Costa Rican hospital.
    Molina J; Barrantes G; Quesada-Gómez C; Rodríguez C; Rodríguez-Cavallini E
    Microb Drug Resist; 2014 Oct; 20(5):478-84. PubMed ID: 24606061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
    Nagy E; Sóki J; Urban E; Szoke I; Fodor E; Edwards R
    Acta Biol Hung; 2001; 52(2-3):271-80. PubMed ID: 11426861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021.
    Fang H; Li X; Yan MK; Tong MK; Chow KH; Cheng VC; Ho PL
    Anaerobe; 2023 Aug; 82():102756. PubMed ID: 37429411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.